Samsrita Labs Ltd
22 February 2025 13:32|BSE : 539267|NSE : None|ISIN : INE579N01018
22 February 2025 13:32|BSE : 539267
NSE : None|ISIN : INE579N01018
Samsrita Labs is at the forefront of research and development in stem cells & regenerative medicine,new drug discovery,RNAi therapeutics, biomarker discovery. The Company was named after late Dr.CM Habeebullah, whose dedication and passion form the backbone of the Company’s core values to provide affordable, world class cutting edge healthcare facilities to all. The Company has been established as an advanced center for research and excellence in the areas of Stem Cell R&D and Therapy, New Drug discovery, Molecular Diagnostics, Stem cell based multi Specialty Hospital and CRO.
Samsrita Labs is at the forefront of research and development in stem cells & regenerative medicine,new drug discovery,RNAi therapeutics, biomarker discovery. The Company was named after late Dr.CM Habeebullah, whose dedication and passion form the backbone of the Company’s core values to provide affordable, world class cutting edge healthcare facilities to all. The Company has been established as an advanced center for research and excellence in the areas of Stem Cell R&D and Therapy, New Drug discovery, Molecular Diagnostics, Stem cell based multi Specialty Hospital and CRO.
FAQs
How to buy Samsrita Labs Ltd shares?
What is the current Market Cap of Samsrita Labs Ltd?
What is the current PE and PB ratio of Samsrita Labs Ltd?
Open Free Demat Account
Kickstart your investment journey
